Significant Wealth Partners LLC Takes Position in Humana Inc. (NYSE:HUM)

Significant Wealth Partners LLC bought a new position in shares of Humana Inc. (NYSE:HUM) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 541 shares of the insurance provider’s stock, valued at approximately $248,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Rakuten Securities Inc. purchased a new position in shares of Humana during the 4th quarter valued at about $25,000. Gradient Investments LLC grew its holdings in Humana by 200.0% during the fourth quarter. Gradient Investments LLC now owns 60 shares of the insurance provider’s stock worth $27,000 after acquiring an additional 40 shares during the period. Cetera Trust Company N.A acquired a new stake in Humana during the fourth quarter worth about $28,000. Nvwm LLC raised its position in Humana by 41.0% during the third quarter. Nvwm LLC now owns 86 shares of the insurance provider’s stock valued at $42,000 after acquiring an additional 25 shares in the last quarter. Finally, Turtle Creek Wealth Advisors LLC acquired a new position in Humana in the fourth quarter valued at approximately $55,000. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, Director Jorge S. Mesquita acquired 545 shares of the stock in a transaction that occurred on Tuesday, February 20th. The stock was purchased at an average price of $367.09 per share, with a total value of $200,064.05. Following the transaction, the director now owns 2,578 shares of the company’s stock, valued at approximately $946,358.02. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.29% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on the stock. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $391.00 price objective on shares of Humana in a research note on Wednesday, April 10th. Royal Bank of Canada dropped their price target on shares of Humana from $507.00 to $415.00 and set an “outperform” rating on the stock in a research report on Friday, January 26th. TD Cowen decreased their price objective on shares of Humana from $427.00 to $396.00 and set a “buy” rating for the company in a research report on Tuesday, April 2nd. Wells Fargo & Company decreased their target price on Humana from $413.00 to $350.00 and set an “overweight” rating on the stock in a research report on Monday, April 8th. Finally, Stephens decreased their price target on shares of Humana from $550.00 to $430.00 and set an “overweight” rating on the stock in a research note on Friday, January 26th. Eleven equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $454.63.

Humana Price Performance

HUM stock opened at $325.30 on Tuesday. Humana Inc. has a 52-week low of $299.23 and a 52-week high of $541.21. The company has a quick ratio of 1.59, a current ratio of 1.59 and a debt-to-equity ratio of 0.63. The stock has a market cap of $39.25 billion, a price-to-earnings ratio of 16.41, a price-to-earnings-growth ratio of 1.92 and a beta of 0.45. The business has a fifty day moving average of $330.09 and a two-hundred day moving average of $399.70.

Humana (NYSE:HUM) last released its quarterly earnings results on Thursday, January 25th. The insurance provider reported ($0.11) earnings per share for the quarter, missing analysts’ consensus estimates of $0.76 by ($0.87). The business had revenue of $26.46 billion for the quarter, compared to analysts’ expectations of $25.47 billion. Humana had a return on equity of 19.44% and a net margin of 2.34%. The business’s revenue for the quarter was up 17.9% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.62 earnings per share. As a group, research analysts anticipate that Humana Inc. will post 16.06 earnings per share for the current year.

Humana Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be paid a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.09%. The ex-dividend date of this dividend is Friday, June 28th. Humana’s dividend payout ratio (DPR) is 17.86%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.